Updated DCRM practice recommendations for diabetes, cardiorenal, and metabolic diseases


An international multidisciplinary task force published updated consensus recommendations for the management of diabetes, cardiorenal, and/or metabolic (DCRM) diseases.

An international volunteer task force comprising experts in cardiology, nephrology, endocrinology and primary care medicine developed the DCRM 2.0 Practice Recommendations, updating and expanding the previous DCRM recommendations from 2022.

Cardiorenal and metabolic diseases share pathophysiological mechanisms and often co-occur in patients. Moreover, recent studies have shown that various treatments have beneficial effects across a range of cardiorenal and metabolic conditions. For these reasons, multispecialty practice recommendations that transcend traditional recommendations of individual medical societies are needed to improve the management of persons with complex conditions involving DCRM diseases.

The recommendations by the task force are bundled in a set of 22 graphics, encompassing general health, cardiorenal risk, cardiorenal and metabolic comorbidities, and implications for management, which can be downloaded here.

Find the DCRM 2.0 Practice Recommendations online at Metabolism

Facebook Comments


We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free